RxDoctor Payments Data

Jean Tersak

Pittsburgh, PANPI 1184692154

Payments from drug & device makers

What this record shows

This record is dominated by education: $36 of the $36 with a category attached, or 100.0%. Servier Pharmaceuticals LLC accounts for 93.0% of it on its own, with 1 other manufacturer making up the rest.

$36in general payments, 2019–2025

Across 4 payments — averaging $8.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Servier Pharmaceuticals LLC$33
  • United Therapeutics Corporation$3
$826,808in research payments, 2019–2025

Across 58 payments — averaging $14,255 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Jazz Pharmaceuticals Inc.$729K
  • Pfizer$26K
  • Incyte Corporation$20K
  • E.r. Squibb & Sons, L.L.C.$18K
  • Daiichi Sankyo Inc.$18K
  • Eli Lilly$16K

What the payments were for

  • Education$36100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Where these figures come from

Is this you, or does something look wrong? →